Insulin aspart, recombinant Subcutaneous and Velpatasvir and Sofosbuvir Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Velpatasvir and Sofosbuvir Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sofosbuvir / velpatasvir
Brand name: Epclusa
Synonyms: Sofosbuvir and velpatasvir, Sofosbuvir and Velpatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Velphoro
- Insulin aspart, recombinant Subcutaneous-Veltassa
- Insulin aspart, recombinant Subcutaneous-Veltin
- Insulin aspart, recombinant Subcutaneous-Veltin Gel
- Insulin aspart, recombinant Subcutaneous-Veltrix
- Insulin aspart, recombinant Subcutaneous-Veltrix Cream
- Velpatasvir and Sofosbuvir Tablets-Insulin degludec
- Velpatasvir and Sofosbuvir Tablets-Insulin Degludec (U-100) Prefilled Pens
- Velpatasvir and Sofosbuvir Tablets-Insulin Degludec (U-100) Vials
- Velpatasvir and Sofosbuvir Tablets-Insulin Degludec (U-200) Prefilled Pens
- Velpatasvir and Sofosbuvir Tablets-Insulin degludec and liraglutide
- Velpatasvir and Sofosbuvir Tablets-Insulin degludec and liraglutide Subcutaneous